Nuclear Trapping of the Forkhead Transcription Factor FoxO1 via Sirt-dependent Deacetylation Promotes Expression of Glucogenetic Genes [PDF]
David Frescas +2 more
openalex +1 more source
Cinnamomum cassia and Their Potential of Antioxidant Activity and Protective Action Against Methomyl Induced Rats Damage With In Silico Docking ABSTRACT Herbal medicine is an important field focused on the treatment and prevention of various health conditions that may occur due to oxidative stress.
Nozza Bouzenna +10 more
wiley +1 more source
Foxj2 Attenuates LPS-Induced Inflammatory Response in Macrophages. [PDF]
Huang P +6 more
europepmc +1 more source
Glucocorticoid Receptor Activation Signals through Forkhead Transcription Factor 3a in Breast Cancer Cells [PDF]
Wei Wu +4 more
openalex +1 more source
AAV‐PHP.eB Peripheral Delivery and Central Expression in Cre Mice
Retro‐orbital injection of AAV‐PHP.eB‐FLEX‐tdTomato into four different strains of Cre mice produced various and distinct patterns of transduction efficiency and tropism across brain regions and cell types. We found many target neurons expressing tdTomato in most but not all strains, along with a low level of nonspecific (Cre‐independent) expression ...
Haidong Zhu, Joel C. Geerling
wiley +1 more source
Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice [PDF]
Pratibha V. Nerurkar +5 more
openalex +1 more source
Tregs improve long‐term neurological recovery after ischemic stroke. Tregs promote ANLS and provide energy supply for neuronal remodeling after stroke. The mechanism underlying Tregs‐mediated ANLS enhancement involves suppression of the STING pathway.
Yao Meng +16 more
wiley +1 more source
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours
Evidence suggests NOTCH activation is among the survival and proliferation pathways interacting with FOXL2 c.402C > G (p.Cys134Trp) mutation in granulosa cell tumours (GCT). This Phase II clinical trial of nirogacestat in GCT achieved its enrolment target in < 1 year and primary analysis within 2 years.
Rachel N. Grisham +20 more
wiley +1 more source
FOXJ3 drives mesenchymal stem cell osteogenic differentiation via the Wnt/β‑catenin pathway: A novel regulator implicated in osteoporosis. [PDF]
Xiao H, Li J, Huang W, Qin Y.
europepmc +1 more source

